Related Experiment Video
Updated: Oct 8, 2026

Alternating Magnetic Field-Responsive Hybrid Gelatin Microgels for Controlled Drug Release
Published on: February 13, 2016
Levan-based hydrogels for controlled release of Amphotericin B for dermal local antifungal therapy of Candidiasis
Tuba Demirci1, Merve Erginer Hasköylü2, Mehmet Sayip Eroğlu3
1IBSB-Industrial Biotechnology and Systems Biology Research Group, Bioengineering Department, Marmara University, Istanbul, Turkey; Institute for Biochemical Engineering and Analytics, THM University of Applied Sciences, Giessen, Germany.
Abstract:
Hydrogels from Halomonas levan polysaccharide were prepared at different crosslinking densities. Swelling results demonstrated pH dependent rather than temperature dependent swelling of the hydrogel and the highest swelling value was achieved at basic conditions with a swelling ratio of 9.1 ± 0.1 which is the highest reported for levan based hydrogels. SEM images show a porous network architecture, which indicates a large surface area of the hydrogels. Rheological analyses showed the viscoelastic behavior of the hydrogels. Biocompatibility of the hydrogels was confirmed by cell culture experiments. For drug release experiments Amphotericin B (AmB) was used. 51% of the loaded AmB was released into the PBS buffer and the released AmB had a significant antifungal activity against Candida albicans.
Related Concept Videos
Candidiasis
Antifungal Agents

